We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$11.9B
AUM Growth
+$2.55B
Cap. Flow
+$1.81B
Cap. Flow %
15.19%
Top 10 Hldgs %
28.34%
Holding
1,181
New
44
Increased
774
Reduced
301
Closed
61

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$294M
2
AAPL icon
Apple
AAPL
+$74.6M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$68.1M
4
TSLA icon
Tesla
TSLA
+$64.9M
5
MSFT icon
Microsoft
MSFT
+$51.6M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$12.3M
2
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$8.37M
3
CLR
CONTINENTAL RESOURCES INC.
CLR
+$7.53M
4
ASML icon
ASML
ASML
+$7.05M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$6.97M

Sector Composition

Rank Sector Weight
1 Technology 34.81%
2 Financials 13.96%
3 Healthcare 11.37%
4 Energy 7.72%
5 Consumer Discretionary 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
251
Exelixis
EXEL
$13.3B
$8.2M 0.07%
511,384
+124,298
+32% +$2.03M
NBIX icon
252
Neurocrine Biosciences
NBIX
$16.8B
$8.2M 0.07%
68,654
+3,525
+5% +$413K
NTLA icon
253
Intellia Therapeutics
NTLA
$1.49B
$8.18M 0.07%
234,464
+104,805
+81% +$4.98M
BMRN icon
254
BioMarin Pharmaceuticals
BMRN
$11.6B
$8.15M 0.07%
78,749
+4,126
+6% +$387K
TDG icon
255
TransDigm Group
TDG
$70.2B
$8.11M 0.07%
12,880
+3,716
+41% +$2.19M
LHX icon
256
L3Harris
LHX
$51.6B
$8.08M 0.07%
38,824
+12,901
+50% +$2.91M
PTCT icon
257
PTC Therapeutics
PTCT
$5.68B
$8.07M 0.07%
211,450
+82,292
+64% +$3.42M
KRTX
258
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$8.07M 0.07%
41,052
+13,226
+48% +$2.84M
HALO icon
259
Halozyme
HALO
$9.79B
$8.06M 0.07%
141,603
-25,692
-15% -$1.32M
RXDX
260
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$8.05M 0.07%
73,189
-21,843
-23% -$1.42M
BLUE
261
DELISTED
bluebird bio
BLUE
$8.05M 0.07%
58,158
+9,629
+20% +$1.36M
EBAY icon
262
eBay
EBAY
$50.6B
$8.02M 0.07%
193,458
-29,046
-13% -$1.2M
NDAQ icon
263
Nasdaq
NDAQ
$52.7B
$8.01M 0.07%
130,579
+14,170
+12% +$883K
UTHR icon
264
United Therapeutics
UTHR
$25.8B
$8M 0.07%
28,772
-2,282
-7% -$576K
RJF icon
265
Raymond James Financial
RJF
$33.8B
$7.97M 0.07%
74,581
+3,408
+5% +$382K
MGY icon
266
Magnolia Oil & Gas
MGY
$6.09B
$7.9M 0.07%
337,047
+52,125
+18% +$1.27M
DNLI icon
267
Denali Therapeutics
DNLI
$3.65B
$7.89M 0.07%
283,742
+76,374
+37% +$2.27M
SIVB
268
DELISTED
SVB Financial Group
SIVB
$7.88M 0.07%
34,231
+5,743
+20% +$1.43M
TWST icon
269
Twist Bioscience
TWST
$5.7B
$7.87M 0.07%
330,350
+173,102
+110% +$5.02M
VIR icon
270
Vir Biotechnology
VIR
$1.46B
$7.81M 0.07%
308,427
-1,150
-0.4% -$28.2K
WDAY icon
271
Workday
WDAY
$39.6B
$7.75M 0.06%
46,286
-16,471
-26% -$2.57M
AEP icon
272
American Electric Power
AEP
$69.6B
$7.67M 0.06%
80,821
-5,848
-7% -$532K
CAT icon
273
Caterpillar
CAT
$375B
$7.67M 0.06%
32,005
+15,179
+90% +$3.3M
ATVI
274
DELISTED
Activision Blizzard
ATVI
$7.62M 0.06%
99,555
-9,941
-9% -$738K
BEAM icon
275
Beam Therapeutics
BEAM
$2.63B
$7.62M 0.06%
194,725
+70,800
+57% +$3.17M
9 10
11
12 13

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Rafferty Asset Management held 1,181 positions worth $11.9B, up 27% from $9.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rafferty Asset Management deployed $1.81B of net new capital in Q4 2022, opening 44 new positions and adding to 774 existing holdings. Its largest new stake was Akero Therapeutics: 187,799 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microchip Technology, an estimated $12.3M trimmed.

  • Rafferty Asset Management's largest Q4 2022 buy was Akero Therapeutics: 187,799 shares worth $10.3M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q4 2022, an estimated $294M increase.
  • Rafferty Asset Management's biggest Q4 2022 reduction was Microchip Technology, cutting an estimated $12.3M.
  • Rafferty Asset Management fully exited CONTINENTAL RESOURCES INC. in Q4 2022, selling an estimated $7.53M.
  • Rafferty Asset Management's ten largest holdings make up 28% of its $11.9B portfolio in Q4 2022.
  • Rafferty Asset Management opened 44 new positions and closed 61 in Q4 2022.
  • Rafferty Asset Management's portfolio value rose 27% quarter-over-quarter to $11.9B.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.